NPY-(22-36) (pig) [5878]



NPY-(22-36) (pig)


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
InChIKey RJIICOGGNWIKON-PIJSUOSGSA-N
Sequence SALRHYINLITRQRY
HELM PEPTIDE1{S.A.L.R.H.Y.I.N.L.I.T.R.Q.R.Y}$$$$

Chemical Properties

Hydrogen bond acceptors 26
Hydrogen bond donors 29
Rotatable bonds 62
Log P -8.073
Molecular weight (Da) 1903.1
Stereochemistry info partial

Database connections

Model (AF2) μ


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

NPY-(22-36) (pig)


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) μ


Compound is not listed as a drug.